Edesa Biotech Inc EDSA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 11/25/22 EST
0.90quote price arrow up+0.0249 (+2.8454%)
Volume
12,570
52 week range
0.76 - 6.80
Loading...
  • Open0.89
  • Day High0.9299
  • Day Low0.89
  • Prev Close0.8751
  • 52 Week High6.80
  • 52 Week High Date11/26/21
  • 52 Week Low0.76
  • 52 Week Low Date11/18/22

Key Stats

  • Market Cap13.916M
  • Shares Out15.46M
  • 10 Day Average Volume0.06M
  • Dividend-
  • Dividend Yield-
  • Beta1.16
  • YTD % Change-84.08

KEY STATS

  • Open0.89
  • Day High0.9299
  • Day Low0.89
  • Prev Close0.8751
  • 52 Week High6.80
  • 52 Week High Date11/26/21
  • 52 Week Low0.76
  • 52 Week Low Date11/18/22
  • Market Cap13.916M
  • Shares Out15.46M
  • 10 Day Average Volume0.06M
  • Dividend-
  • Dividend Yield-
  • Beta1.16
  • YTD % Change-84.08

RATIOS/PROFITABILITY

  • EPS (TTM)-1.31
  • P/E (TTM)-0.69
  • Fwd P/E (NTM)-2.28
  • EBITDA (TTM)-20.901M
  • ROE (TTM)-133.29%
  • Revenue (TTM)-
  • Gross Margin (TTM)-362.00%
  • Net Margin (TTM)-2,334,322.00%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date12/17/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Edesa Biotech Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Edesa Biotech, Inc. is a Canada-based biopharmaceutical company. The Company is focused on acquiring, developing and commercializing clinical stage drugs for inflammatory and immune related diseases with clear unmet medical needs. It is organized under the laws of British Columbia, Canada. The Company’s two lead product candidates, EB05 and EB01, are in later stage clinical studies. EB05 is a monoclonal antibody therapy, which the Company is developing as a treatment for...
Sean Macdonald
Independent Chairman of the Board
Pardeep Nijhawan M.D.
Chief Executive Officer, Corporate Secretary and Director
Michael Brooks Ph.D.
President
Kathi Niffenegger CPA
Chief Financial Officer
Address
100 Spy Crt
Markham, ON
L3R 5H6
Canada

Top Peers

SYMBOLLASTCHG%CHG
LMNL
Liminal BioSciences Inc
0.46UNCHUNCH
CWBR
CohBar Inc
1.61+0.03+1.90%
KTRA
Kintara Therapeutics Inc
3.69+0.04+1.10%
MYCO
APLI